Bull run! The park won 1 top + 8 majors!

Today (July 10)

2023 (15th) Suzhou International Elite Entrepreneurship Week

And the 4th "Suzhou Scientist Day" event

Grand Opening

The conference is the top talent team in Suzhou

Issued a certificate with the Gusu major innovation team

Suzhou Industrial Park once again amazed the audience

picture
from the park

Rao Yi's team won the top talent team

1/3 of the city

8 major innovation teams were selected

4/5 of the city

 

Top talent team

Suzhou Huayi Lejian Biotechnology Co., Ltd.

Rao Yi Team

Focus on innovative gene therapy products

Committed to building a foothold in China

The world's leading biotechnology company

Hua Yi Le Jian

Huayi Lejian was established in 2019 by Professor Rao Yi, a famous biologist. The company takes "Standing for China, and the people are happy and healthy" as its mission, with independent innovation and research and development as the core, and is committed to building a China-based, The world's leading biotechnology company, benefiting human health. The scientific founder Professor Rao Yi led the team to transform years of scientific accumulation into disruptive innovative gene therapy products. At present, the company has established 8 product pipelines in three major directions, and has built products that balance rare diseases and common diseases pipeline layout. In 2021, the company was rated as a major science and technology leading talent enterprise in the park and a Suzhou leading talent enterprise.

 

Major Innovation Team

Qinhao Pharmaceutical (Suzhou) Co., Ltd.

Li Jie team

Study diligently and learn for a living

Let the original new medicine go from Suzhou to the world

Qinhao Pharmaceutical

Qinhao Pharmaceutical is a biotechnology company focusing on the development of the world's leading small molecule anti-tumor new drugs. The company implements the "Biology-driven Smart Design" research and development strategy, uses the combined technology platform to deeply cultivate the RAS signaling pathway (1.0 pipeline), and focuses on the field of synthetic lethality (2.0 pipeline). At present, 3 products are in the clinical trial stage, and several products are in the IND enabling stage.

Thanks to its own complete innovative drug R&D strategic planning and implementation capabilities, the overseas rights and interests of the small molecule SHP2 inhibitor GH21 with global intellectual property rights have been licensed to HUYA Biotech in the United States with a total milestone payment of US$282 million. Obtain the sales commission in the global market after the product is launched. In 2013, the company was rated as a leading science and technology talent enterprise in the park.

 

Suzhou Ruixin Integrated Circuit Technology Co., Ltd.

Fan Dongrui Team

Foundry's Heaviest Weapon

Helping innovation and upgrading of high-end processor chips

Core Chip Integrated Circuit

Corechip IC has the earliest team in China to develop high-performance multi-core/many-core processors. It has 20 years of experience in high-end chip research and development and industry experience. The main technology direction is based on the open instruction set RISC-V, high-performance server processors The R&D, design and industrialization of chips (CPU) and accelerator chips (DF-GPU) are committed to breaking the blockade of X86, ARM and other instruction sets, and realizing the independent control of the core technology of domestic high-end chips. In 2021, the company was rated as a major science and technology leading talent enterprise in the park.

 

Suzhou Yige Technology Co., Ltd.

Wang Qiang team

Helping the era of AI intelligence

Be a leader in the field of FPGA chips

Heterogeneous technology
Yige Technology focuses on the research and development and design of domestic high-end FPGA chips and dedicated EDA tool chain software to create domestic high-end advanced chips and become a leader in the high-end FPGA track. The company's main business is the R&D, design and sales of mid-to-high-end FPGA chips and dedicated EDA tool software.

Focus on solving the "stuck neck" problem of FPGA among the four national key chips (CPU, GPU, FPGA, DSP), create greater value for customers with innovative technology and open ecology, and strive to become a leader in the field of FPGA chips. The company's first chip is positioned above 500K, filling the domestic gap, and realizing the independent controllability of EDA special tool chain and FPGA chip. In 2022, the company was rated as a leading science and technology talent enterprise in the park.

 

Fangtuo Biotechnology (Suzhou) Co., Ltd.

Dai Yong's team

"Expand" on the shore of Jinji Lake

Let the gene therapy drug "made in China"

light the way of life

 

Fangtuo biological

Focusing on the field of rare diseases and chronic diseases, Fangtuo Bio is committed to the development and production of high-quality recombinant adeno-associated virus (rAAV) vector gene therapy products that patients can afford. The company has built a full-chain platform system for innovative drug research and development, including vector construction and screening, GMP production, etc. Its AAV vector construction platform can screen out drugs based on tissue specificity, transduction efficiency, safety, and scalability of production processes. Optimal AAV capsids to achieve sufficiently high levels of gene expression of interest with relatively low doses of AAV vectors.

At present, the company has completed the B-round financing of US$160 million, and three products have entered the clinical trial stage. In 2021, the company was rated as a leading talent enterprise in science and technology in the park.

 

Suzhou Argo Space Technology Co., Ltd.

Lin Jun Team

From "footstep measurement" to "space remote sensing"

Be a pioneer in the field of commercial remote sensing technology

Argo
Argo it is the first commercial aerospace company in China to provide batches of optical main payloads as one of its main businesses. Based on the "high timeliness, high geometry, hyperspectral" imaging technology with independent intellectual property rights, it constructs optical payloads that meet the application needs of various fields Technology and product system, while carrying out constellation operation and data application services, and is committed to becoming the world's leading provider of optical remote sensing payload products and services.
The company closely focuses on the new requirements of high-efficiency observation of the earth in the military and civilian fields, and attaches equal importance to maps and spectra. It has developed a series of new spectral remote sensing load products, which have won wide acclaim from users and the commercial remote sensing market. scientific research team. In 2021, the company was rated as a leading talent enterprise in science and technology in the park, and in 2022 as a leading talent enterprise in Suzhou.

 

Huili Pharmaceutical (Suzhou) Co., Ltd.

Xu Ping team

Develop new drugs with new targets

Fill in the blank of domestic high-end complex preparations

Protect national health

Huili Pharmaceutical
Huili Pharmaceuticals focuses on the research and development of new targets and new drugs characterized by long-acting sustained-release microsphere preparations and new drug delivery, and has created an internationally leading and independently innovative drug delivery technology (DDS) platform. At present, the company focuses on mental health, diabetes, tumors and pain, among which the first long-acting microsphere preparation in the pain domain has obtained clinical approval and has begun clinical trials; drugs in the spiritual domain have obtained clinical approval in May this year, which will fill the domestic high-end complex Preparation blank. In 2021, the company was rated as a leading talent enterprise in science and technology in the park and a leading talent enterprise in Suzhou.

 

Suzhou Yilian Biomedicine Co., Ltd.

Xue Tongtong Team

Committed to the research and development of original conjugated drugs

Build a solid line of defense for cancer patients

Yilian Biotech
Founded by a senior team with all-round experience in ADC, Yilian Biotech is committed to the development of drug conjugates with international competitiveness. It has pioneered a new generation of linker-payload technology with revolutionary potential, and has established a rich product pipeline. Several varieties are in clinical research, and it is expected to obtain ADC varieties with better efficacy, better safety, and wider indications. In 2021, the company was rated as a leading talent enterprise in science and technology in the park and a leading talent enterprise in Suzhou.

 

Suzhou Navitas Technology Co., Ltd.

Chen Wu Team

Breaking through the technical barriers of new materials

Dare to be the "leader" in the field of separation and purification

Navitas Technology

Navitas Technology has always adhered to the concept of "Innovation, Winning Respect, Winning the Future", insisted on technological innovation for a long time, and developed the world's leading microsphere precision preparation technology.

The company's patented technology can precisely control the composition of microsphere materials, particle size and distribution, structural morphology, pore size and distribution, surface modification and functional groups, etc. It is currently one of the few in the world that can mass produce ultra-pure Silica gel, hybrid silica gel, polystyrene, polyacrylate-based monodisperse chromatographic packing materials, a state-level specialized special new little giant company, has been listed on the Shanghai Science and Technology Innovation Board in June 2021. In 2007, the company was rated as a leading talent enterprise in science and technology in the park, and in 2008 as a leading talent enterprise in Gusu.

 

Closely linked to mass entrepreneurship and talent gathering

Introduce and develop "new force"

Create a blessed land for high-level talents and a highland for innovation and entrepreneurship

boost construction

An open and innovative world-class high-tech park

 

The 15th Suzhou International Elite Entrepreneurship Week park sub-venue series of activities was unveiled on July 10-12, closely following the needs of the integrated development of industrial innovation clusters in the era of digital economy, and comprehensively displaying the first-class innovation and entrepreneurship ecology of the park, in the global coordinates The department gathers talents from all over the world to fully activate the innovative vitality and core competitiveness of talents on the new journey of building the "four first-class".

This year's Entrepreneurship Week Park sub-venue sub-item activities are carried out in the form of "1+4", "1" refers to the talent-led industrial innovation cluster development conference, which focuses on the support and empowerment of the park to top talents, and fully releases the magnetism of the world's talents Attractive force; "4" refers to four types of activities, namely industry-talent matchmaking, theme forums, roadshow events, and immersive experiences, to promote the in-depth integration of elements such as talents, projects, technology, and capital, and create a never-ending talent carnival in the park.